Medicare Enrolled

Dr. William Biggs, M.D.

Endocrinology · Amarillo, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1215 S COULTER ST, Amarillo, TX 79106
8063588331
In practice since 2006 (19 years)
NPI: 1033280862 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Biggs from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Biggs? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Biggs

Dr. William Biggs is an endocrinology in Amarillo, TX, with 19 years in practice. Based on federal Medicare data, Dr. Biggs performed 22,507 Medicare services across 9,710 unique beneficiaries.

Between the years covered by Open Payments, Dr. Biggs received a total of $45,923 from 42 pharmaceutical and/or device companies across 588 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Biggs is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 2% volume in TX$ $45,923 industry payments

Medicare Practice Summary

Medicare Utilization ↗
22,507
Medicare services
Top 2% in TX for endocrinology
9,710
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,185 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Blood draw (venipuncture)2,214$6$7
Office visit, established patient (30-39 min)2,213$84$155
Bilirubin level, direct2,092$5$9
Comprehensive metabolic blood panel2,086$10$20
Denosumab injection (Prolia/Xgeva)2,040$18$35
Hemoglobin A1c test (diabetes monitoring)1,628$9$18
Lipid panel (cholesterol and triglycerides)1,626$13$26
Ldl cholesterol level1,592$10$16
Free thyroxine (T4) test1,124$9$18
Thyroid stimulating hormone (TSH) test1,115$16$30
Complete blood count (CBC) with differential616$8$14
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report427$25$45
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month337$45$72
Urinalysis with microscopic exam232$3$6
Uric acid level test225$4$9
Ultrasound scan of head and neck soft tissue221$59$101
Thyroid hormone, t3 measurement, free209$17$31
Urine microalbumin (protein) analysis170$6$8
Vitamin D level test164$28$46
Flu vaccine administration153$24$25
Thyroglobulin (thyroid protein) antibody measurement149$15$76
Parathyroid hormone level test142$40$152
Phosphate level test122$5$20
Flu vaccine, high-dose118$69$75
Creatinine test (kidney function)113$5$8
Drug injection, under skin or into muscle113$10$28
Urine microalbumin test (kidney screening)110$6$9
Ferritin level test (iron stores)89$13$53
Magnesium level test89$7$20
Microsomal antibodies (autoantibody) measurement85$14$56
Chronic care management, first 20 min/month76$46$64
Thyroglobulin (thyroid related hormone) level67$16$150
Hepatitis c antibody measurement65$14$60
Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment64$49$93
COVID-19 vaccine administration53$39$48
COVID-19 vaccine (Moderna bivalent)53$143$155
New patient office visit, complex (60-74 min)48$152$241
Fine needle aspiration biopsy using ultrasound guidance, first growth43$95$148
Office visit, established patient (20-29 min)39$64$107
Basic metabolic blood panel33$7$21
Office visit, established patient, complex (40-54 min)33$134$205
Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk31$24$56
Vitamin B-12 level test29$15$30
Testosterone (hormone) level, total29$25$43
Creatinine clearance measurement to test for kidney function24$9$29
Total protein level, urine24$3$42
Prolactin (milk producing hormone) level22$19$82
Dxa bone density measurement of forearm, finger, hand, or foot20$30$42
Cortisol (hormone) measurement, total20$16$65
Bone density scan (DEXA)18$36$83
Folic acid level test18$14$25
Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage16$22$40
Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month16$36$52
New patient office visit (45-59 min)15$110$192
Creatine kinase (cardiac enzyme) level, total13$6$21
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin13$43$63
Prostate cancer screening; prostate specific antigen test (psa)11$19$73
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$45,923
Total received (2018-2024)
Avg $6,560/year across 7 years
Top 15% in TX for endocrinology
42
Companies
588
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,370 (57.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$17,993 (39.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,561 (3.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,537
2023
$3,025
2022
$1,777
2021
$1,751
2020
$2,719
2019
$29,896
2018
$5,218

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Roche Diabetes Care, Inc.
$18,040
Novo Nordisk AS
$13,486
Novo Nordisk Inc
$2,212
Tandem Diabetes Care, Inc.
$1,795
Amgen Inc.
$1,536
Medtronic MiniMed, Inc.
$1,125
Boehringer Ingelheim International GmbH
$1,085
AstraZeneca Pharmaceuticals LP
$893
Boehringer Ingelheim Pharmaceuticals, Inc.
$772
Lilly USA, LLC
$634
Dexcom, Inc.
$496
SANOFI-AVENTIS U.S. LLC
$493
Abbott Laboratories
$474
AbbVie Inc.
$334
Radius Health, Inc.
$303
Janssen Pharmaceuticals, Inc
$258
Horizon Therapeutics plc
$198
Xeris Pharmaceuticals, Inc.
$193
Insulet Corporation
$177
AbbVie, Inc.
$160
GlaxoSmithKline, LLC.
$135
RECORDATI_RARE_DISEASES_INC.
$134
Merck Sharp & Dohme Corporation
$118
PFIZER INC.
$113
Alexion Pharmaceuticals, Inc.
$104
Mannkind Corporation
$96
ABBVIE INC.
$93
MannKind Corporation
$83
Corcept Therapeutics
$66
Amarin Pharma Inc.
$59
DEXCOM, INC.
$42
Bayer Healthcare Pharmaceuticals Inc.
$31
SANOFI PASTEUR INC.
$28
ViiV Healthcare Company
$22
Bayer HealthCare Pharmaceuticals Inc.
$22
Ultragenyx Pharmaceutical Inc.
$19
EUSA Pharma (US) LLC
$17
Analog Devices Inc.
$16
Companion Medical, Inc.
$16
Siemens Medical Solutions USA, Inc.
$16
Senseonics, Incorporated
$15
Sanofi Pasteur Inc.
$14
Top 3 companies account for 73.5% of total payments
Associated products mentioned in payments ›
AFREZZA · ALINITY · Androgel · BAQSIMI · BYDUREON · Cables · DC ACCU-CHEK Diabetes Management Solutions · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · Eversense · FARXIGA · FIASP · FLUBLOK QUADRIVALENT · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · GVOKE PFS · HUMULIN · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · Kerendia · Kits and Accessories · Korlym · LANTUS · LYUMJEV · Levemir · MOUNJARO · Minimed 670G System · Omnipod · Ozempic · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROCLAIM · Proclaim IPG · Prolia · RECORLEV · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATOM GO · STRENSIQ · SYNTHROID · Sensinel CPM Wearable · Software · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRIUMEQ · TRULICITY · TZIELD · Tresiba · Tymlos · Vascepa · Victoza · Wegovy · XARELTO · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (57%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $204 per 100 Medicare services performed
Looking for a endocrinology in Amarillo?
Compare endocrinologys in the Amarillo area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
9
Per 100K population
7.7
County median income
$50,448
Nearest hospital
NORTHWEST TEXAS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Biggs is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 15%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Biggs experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Biggs performed 2,214 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Biggs receive payments from pharmaceutical companies?
Yes. Dr. Biggs received a total of $45,923 from 42 companies across 588 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Biggs's costs compare to other endocrinologys in Amarillo?
Dr. Biggs's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Biggs) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →